Join us at ESCMID. Dr. Ardjan van der Linden, CSO of ShanX Medtech, will be presenting interim clinical study results from the Dutch point-of-care setting at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ESCMID). Join the poster talk on Monday, April 14th at 11:00 AM in Arena 3. This new data builds on the momentum of last year’s impressive findings from our clinical study at Erasmus Medical Center, presented at ESCMID 2024 in Barcelona. We’re on a mission to make next-generation Antibiotic Susceptibility Testing (AST) accessible across all healthcare settings: from hospitals to clinics to the point of care.